Hyperlipaemia in experimental nephrosis and its control by chlorophenoxyisobutyrate and betabenzalbutyrate.
D000818:Animals; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002087:Butyrates / Q000627:therapeutic use*; D004195:Disease Models, Animal; D006949:Hyperlipidemias / Q000139:chemically induced / Q000188:drug therapy* / Q000517:prevention & control; D008099:Liver / Q000187:drug effects / Q000503:physiopathology; D009402:Nephrosis, Lipoid / Q000139:chemically induced* / Q000150:complications; D009705:Nucleosides; D011422:Propionates / Q000627:therapeutic use*; D011691:Puromycin; D051381:Rats
D000924:Anticholesteremic Agents; D002087:Butyrates; D009705:Nucleosides; D011422:Propionates; D011691:Puromycin